Schedule 13G ownership disclosure

BIOCRYST PHARMACEUTICALS INC

Security class unavailable · CUSIP: 09058V103

Event date: 2016-08-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,740,239
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-120555
Form type
SC 13G
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
Aug 22, 2016
Reporting period
Aug 11, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub